Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Mar;10(2):72-7.
doi: 10.1007/BF02897996.

INK4 Family -A promising target for 'gene-regulating chemoprevention' and 'molecular-targeting prevention' of cancer

Affiliations

INK4 Family -A promising target for 'gene-regulating chemoprevention' and 'molecular-targeting prevention' of cancer

Youichirou Matsuzaki et al. Environ Health Prev Med. 2005 Mar.

Abstract

Inactivation of the p16(INK4a) gene is one of the most frequent defects that contribute to oncogenesis in human cancer, since it is a tumor-suppressor gene. Therefore, functional restoration of p16(INK4a) is one of the most effective methods for cancer prevention. We proposed the concept of 'gene-regulating chemoprevention' and 'molecular-targeting prevention' of cancer, which assumes that transcriptional regulation by drugs on tumor-suppressor genes or functionally similar genes to the tumor-suppressor genes contributes to the prevention of human malignancies. The p16(INK4a) homologs p15(INK4b), p18(INK4c) and p19(INK4d) have been recently identified, and these four members constitute the INK4 family of proteins. All directly bind to cyclin D-cyclin dependent kinase (CDK) 4/6 and are therefore specific inhibitors of these complexes. We recently showed that histone deacetylase (HDAC) inhibitors, promising chemopreventive and chemotherapeutical agents, induce p15(INK4b) and p19(INK4d) gene expression and cause growth arrest, suggesting that both genes are important molecular targets for HDAC inhibitors. Furthermore, we found that 12-O-tetradecanoylphorbol-13-acetate (TPA), which is widely used as a tumor promoter and protein kinase C activator, promotes human cancer cell growth through the down-regulation of p18(INK4c) gene expression. This suggests that a mouse two-stage carcinogenesis model using TPA might partially represent the most common human carcinogenesis pathway related to RB. Our results suggest that the INK4 family consists of attractive and promising molecular targets for the 'gene-regulating chemoprevention' and 'molecular-targeting prevention' of cancer.

Keywords: INK4 family; TPA; histone deacetylase inhibitors; p15INK4b; p16INK4a; p18INK4c; p19INK4d; prevention; protein kinase C.

PubMed Disclaimer

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/1097-0142(19930801)72:3+<962::AID-CNCR2820721303>3.0.CO;2-H', 'is_inner': False, 'url': 'https://doi.org/10.1002/1097-0142(19930801)72:3+<962::aid-cncr2820721303>3.0.co;2-h'}, {'type': 'PubMed', 'value': '8334671', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8334671/'}]}
    2. Pitot HC. The molecular biology of carcinogenesis. Cancer. 1993; 72: 962–970. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1038/nrc844', 'is_inner': False, 'url': 'https://doi.org/10.1038/nrc844'}, {'type': 'PubMed', 'value': '12094240', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12094240/'}]}
    2. Sporn MB, Suh N. Chemoprevemtion: an essential approach to controlling cancer. Nature Rev Cancer. 2002; 2: 537–543. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1038/sj.onc.1202998', 'is_inner': False, 'url': 'https://doi.org/10.1038/sj.onc.1202998'}, {'type': 'PubMed', 'value': '10498883', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10498883/'}]}
    2. Roussel MF. The INK4 family of cell cycle inhibitors in cancer. Oncogene. 1999; 18: 5311–5317. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9823374', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9823374/'}]}
    2. Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta. 1998; 1378: F115-F177. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1038/35092584', 'is_inner': False, 'url': 'https://doi.org/10.1038/35092584'}, {'type': 'PubMed', 'value': '11544530', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11544530/'}]}
    2. Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature. 2001; 413: 83–86. - PubMed

LinkOut - more resources